Akebia Therapeutics Inc.
AKBA | NASDAQ
$0.98
+$0.04 (+4.42%)
Sep 22, 2026, 12:57 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 219.06M | 232.4M | 236.19M | 225.07M | 203.73M | 184.91M | 160.18M | 169.88M | 174.5M | 187.23M | 194.62M | 193.61M | 200.28M | 270.26M | 291.96M | 294.46M | 294.5M | 221.05M | 211.65M | 210.67M | 221.9M | 259.13M |
Cost of Revenue | 44.96M | 44.46M | 39.46M | 47.61M | 52.07M | 50.45M | 45.54M | 43.84M | 47.69M | 56.67M | 74.15M | 52.39M | 72.66M | 73.98M | 85.13M | 119.95M | 97.61M | 131.51M | 134.77M | 129.87M | 144.27M | 266.39M |
Gross Profit | 174.1M | 187.95M | 196.73M | 177.46M | 151.66M | 134.46M | 114.64M | 126.04M | 126.81M | 130.55M | 120.48M | 141.22M | 127.62M | 196.29M | 206.83M | 174.51M | 196.89M | 89.54M | 76.88M | 80.8M | 77.64M | -7.26M |
Operating Income | -15.13M | 5.29M | 23.5M | 17.75M | 791K | -22.02M | -50.47M | -34.79M | -35.32M | -35.59M | -46.26M | -53.98M | -91.35M | -48.28M | -81.17M | -140.16M | -144.64M | -258.06M | -264.5M | -284.57M | -287.78M | -382.25M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -27.85M | -18.76M | -3.72M | -15.29M | -36.48M | -45.31M | -69.41M | -45.99M | -40.44M | -43.03M | -51.92M | -60.09M | -99.7M | -59.08M | -94.62M | -156.93M | -162.38M | -274.87M | -282.02M | -299.16M | -299.58M | -392.29M |
Net Income | -29.67M | -20.51M | -5.35M | -15.91M | -36.48M | -45.31M | -69.41M | -45.99M | -40.44M | -43.03M | -51.92M | -60.09M | -99.7M | -59.08M | -94.62M | -156.93M | -162.38M | -274.87M | -282.02M | -299.16M | -299.58M | -392.29M |
Selling & General & Admin | 114.69M | 113.07M | 108.38M | 109.96M | 106.49M | 79.93M | 54.19M | 51.95M | 48.15M | 75.18M | 100.24M | 105.45M | 114.62M | 119.83M | 139.1M | 153.26M | 167.73M | 178.03M | 175.03M | 170.54M | 165.07M | 159.05M |
Research & Development | 70.14M | 67.09M | 62.04M | 47.18M | 41.04M | 37.67M | 37.65M | 35.73M | 40.57M | 53.12M | 63.08M | 85.12M | 99.82M | 105.65M | 129.79M | 127.44M | 139.89M | 151.07M | 147.85M | 155.87M | 162.26M | 177.87M |
Other Expenses | 4.4M | 2.49M | 2.82M | 2.58M | 3.34M | 38.88M | 73.27M | 73.15M | 73.41M | 37.84M | 3.42M | 4.64M | 4.53M | 19.09M | 19.11M | 33.97M | 33.91M | 18.49M | 18.5M | 38.96M | 38.5M | 38.87M |
Operating Expenses | 189.22M | 182.66M | 173.23M | 159.72M | 150.87M | 156.48M | 165.11M | 160.83M | 162.13M | 166.15M | 166.73M | 195.2M | 218.96M | 244.57M | 288M | 314.67M | 341.53M | 347.6M | 341.38M | 365.37M | 365.41M | 375M |
Interest Expense | 7.96M | 11.72M | 24.18M | 26.23M | 28.14M | 23.46M | 18.19M | 12.73M | 7.48M | 6.97M | 6.03M | 6.25M | 8.79M | 12.19M | 15.69M | 19.13M | 20.27M | 20.19M | 19.94M | 17.17M | 14.36M | 11.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | 4.6M | 4.6M | 4.6M | 4.6M | 25.44M | 48.15M | 75.18M | 100.4M | 105.61M | 114.79M | 120M | 139.1M | 116.65M | 131.12M | 98.88M | 95.88M | 92.69M | 46.33M | 46.33M |
Cost & Expenses | 234.18M | 227.11M | 212.7M | 207.33M | 202.94M | 206.93M | 210.65M | 204.67M | 209.82M | 222.82M | 240.88M | 247.59M | 291.62M | 318.54M | 373.13M | 434.62M | 439.14M | 479.1M | 476.15M | 495.24M | 509.68M | 641.39M |
Income Tax Expense | 1.82M | 1.75M | 1.62M | 615K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 269.6M | 267.05M | 265.37M | 264.79M | 262.57M | 235.5M | 218.7M | 210.35M | 209.71M | 204.96M | 189.9M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 183.6M | 179.6M | 174.65M | 173.78M | 161.33M | 153.82M |
Shares Outstanding (Diluted) | 269.6M | 267.05M | 265.37M | 274.37M | 271.1M | 241.6M | 218.7M | 210.35M | 209.71M | 204.96M | 190.5M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 190.38M | 179.6M | 175.61M | 173.78M | 161.33M | 153.82M |
EPS (Basic) | -0.11 | -0.08 | -0.02 | -0.07 | -0.17 | -0.21 | -0.33 | -0.22 | -0.20 | -0.22 | -0.22 | -0.27 | -0.49 | -0.27 | -0.53 | -0.88 | -0.93 | -1.60 | -1.70 | -1.90 | -1.98 | -2.75 |
EPS (Diluted) | -0.11 | -0.08 | -0.02 | -0.07 | -0.17 | -0.21 | -0.33 | -0.22 | -0.20 | -0.22 | -0.22 | -0.27 | -0.49 | -0.28 | -0.54 | -0.89 | -0.94 | -1.60 | -1.70 | -1.90 | -1.98 | -2.75 |
EBITDA | -18.01M | -5.76M | 21.73M | 21.23M | 11.01M | 4.8M | -14.31M | 3.7M | 4.04M | 2.73M | -8.27M | -2.51M | -39.55M | 4.48M | -27.54M | -92.7M | -96.96M | -209.91M | -217.23M | -216.76M | -222.85M | -317.64M |
EBIT | -19.89M | -7.04M | 20.46M | 10.94M | -8.34M | -23.65M | -51.82M | -33.86M | -33.56M | -34.87M | -45.89M | -40.15M | -77.21M | -33.2M | -65.24M | -130.43M | -134.75M | -247.31M | -254.73M | -252.53M | -255.76M | -351.12M |
Depreciation & Amortization | 1.88M | 1.28M | 1.27M | 10.29M | 19.35M | 28.44M | 37.5M | 37.56M | 37.6M | 37.59M | 37.63M | 37.64M | 37.66M | 37.68M | 37.7M | 37.73M | 37.79M | 37.4M | 37.5M | 35.77M | 32.91M | 33.49M |
Add to Watchlist
Select watchlists to add or remove AKBA